News
Novo Nordisk CEO to Step Down
Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s successor is ongoing. Novo Nordisk says the leadership transition is “made in light of the recent market challenges Novo Nordisk has been facing, and the development of the company’s share price since mid-2024.”
Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. AstraZeneca's run of positive ...
Hosted on MSN11mon
Novo Nordisk CEO to testify before Senate on Ozempic pricingNorvo Nordisk (NVO) (OTCPK ... after the Danish pharma giant’s CEO agreed to testify before the Senate later this year. Sen. Bernie Sanders (I-Vt.), the chairman of the Senate Committee on ...
Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback